Private Equity

Updated:

NQV8

John Kuenzi and Cole Ahlvers built NQV8 as a pet-nutrition operating partner that embeds inside startups from concept to shelf.

NQV8 logo

NQV8

NQV8 offers unique solutions for early-stage startups and pet entrepreneurs.

General information

Firm type

Private Equity

Year founded

AUM

Undisclosed

Location

Region

North America

Country

United States

City

Manhattan

Corporate office

Manhattan, United States

Principals

John Kuenzi

CEO

Cole Ahlvers

President

Bob Howard

VP of Operations

John Krehbiel

VP of Sales

Lynette Strathman

CFO

Sector focus

Pet CareFood & Beverage

Frequently asked questions

Does NQV8 operate a venture fund or pool third-party capital?

No fund structure is disclosed. NQV8 describes itself as an 'Innovation Incubation' partner that provides operational expertise—formulation, manufacturing introductions, production management—rather than pre-committed capital. The model likely uses fee-for-service or services-for-equity arrangements, making it structurally distinct from a GP-led venture fund.

How does NQV8 source the companies it works with?

The firm sources through a network of 'validated Tier One Producers,' critical influencers, and supply experts accumulated over a combined 150-plus years in the pet industry. Public testimonials from manufacturer executives at Alphia and Simmons Pet Food confirm that NQV8 actively facilitates introductions between emerging brands and large-scale producers.

What stages of company development does NQV8 typically target?

NQV8 works across the full development arc—from concept and strategic planning through formulation, manufacturing scale-up, and commercialization. Testimonials from CEOs at Jinx and Native Pet describe the firm supporting both ground-up development and existing-project acceleration.

Is NQV8 exclusively focused on pet food, or does it cover other animal-health verticals?

The firm's stated mission references 'the Biotech (Animal Health) Canopy,' but all public case references and service descriptions are concentrated in pet food, treats, and supplements. No companion-animal pharma or veterinary device engagements are cited on the website.

Who makes investment decisions at NQV8?

The website does not outline a formal investment committee. CEO John Kuenzi and President Cole Ahlvers are the most senior named executives, and both appear in client testimonials as project leads, suggesting the two jointly direct which partnerships the firm enters.

Does NQV8 co-invest alongside external GPs or strategic buyers?

No public record of co-investment activity exists. The firm does not market itself as a capital provider; its value proposition is operational execution, which may occasionally be compensated via equity but has not been documented alongside institutional co-investors.

How does NQV8 compare to other pet-focused investors or incubators?

Unlike pet-care venture funds such as Mars' Companion Fund or digital-native holding companies, NQV8 does not disclose a pool of committed capital. Its team-centric, production-floor model more closely resembles a consulting-and-execution partner for hire, competing through manufacturing relationships and formulation expertise rather than check size.

Profile maintained by using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.

Need institutional-grade insight on private equity firms?

Altss delivers:

Principals with verified direct contactsAllocation history by asset classOSINT-derived deal signals
Book a demo

Prefer a guided tour?

We’ll walk you through:

Interactive funding timelinesCustom mandate & allocation filters
Book a demo

Browse by category

More Manhattan Private Equity profiles